Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.
This is a short WorldPing brief. The full report was published by CNBC.
Read the full report at CNBCMore coverage: all business news on WorldPing.
WorldPingAs the first sitting president visit to Gracie Mansion in decades, Trump backsed mayor's Sunnyside Yards push.
Brief by WorldPing · Original reporting by Fortune
WorldPingLarge network balances sit alongside uneven ETF flows, while the benefit to ETH holders depends on purchases and fees.
Brief by WorldPing · Original reporting by CryptoSlate
WorldPingThe fall equinox, which arrives Tuesday in the U.S., brings shorter days, and chances to witness alignment between Earth and the sun. It's a modern version of ancient observances of a celestial shift.
Brief by WorldPing · Original reporting by NPR Top
WorldPingThe latest addition to X's Under the Hood feature could stave off claims around shadowbanning.
Brief by WorldPing · Original reporting by Engadget
They're the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.
Brief by WorldPing · Original reporting by CNBC World
WorldPingShares in Grail, the company developing a blood test for cancer, surged Monday after the FDA posted documents ahead of an advisory committee meeting.
Brief by WorldPing · Original reporting by STAT
WorldPing